Skip to content

Comparing combination of two drugs namely 0.25 percent Ropivacaine and Dexmedetomidine when used with Clonidine in nerve blocks to compare pain relief in patients aged 18 to 64 yrs who are posted for shoulder arthroscopic surgeries

Comparison of 0.25 percent Ropivacaine with Dexmedetomidine vs Clonidine as an adjuvant in Interscalene Brachial plexus block for post operative analgesia in shoulder arthroscopy. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095269
Enrollment
42
Registered
2025-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Group 1 - Inj 0.25 % Ropivacaine + Clonidine: Patients randomised into group 1 will receive an interscalene brachial plexus block with 0.25 percent Ropivacaine plus Clonidine. Control I

Sponsors

ST JOHNS MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age group- 18 - 59years, 2) Scheduled for elective shoulder arthroscopic surgeries under GA 3) ASA Grade I and II patients

Exclusion criteria

Exclusion criteria: 1) Patient refusal 2) Bleeding disorders 3) Patients with known local anesthetic sensitivity 4) morbidly obese patients 5) Previous h/o upper limb nerve damage 6) Respiratory insufficiency 7) Infection at the block location.

Design outcomes

Primary

MeasureTime frame
To compare the effect of 12 ml of 0.25% Ropivacaine + Dexmedetomidine vs 12 ml of 0.25% Ropivacaine + Clonidine on duration of analgesia when used in Interscalene Brachial Plexus block for shoulder arthroscopy.Timepoint: Postoperatively VAS scores of patients will be assessed for 2,4,6,8,10,12,24 hrs

Secondary

MeasureTime frame
1)VAS Score over 24 hours 2)Time to first request of post operative analgesia 3)Total IV PCA Fentanyl consumption over 24 hrs Timepoint: Vas score will be assessed at 2,4,6,8,10,12,24 hrs post block

Countries

India

Contacts

Public ContactDr Sandra Monis

St. Johns Medical College and Hospital, Bangalore

drnischala01@gmail.com9535148078

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026